Successful use of tofacitinib in reactive arthritis refractory to conventional therapies - a case series.
Mod Rheumatol Case Rep
; 6(2): 167-170, 2022 06 24.
Article
em En
| MEDLINE
| ID: mdl-35024869
Reactive arthritis is an immune-mediated aseptic arthritis resulting from either genitourinary or gastrointestinal tract in a genetically susceptible host. It commonly presents as oligoarthritis of the lower limbs with or without extra-articular features such as urethritis and non-purulent conjunctivitis. Therapies include non steroidal anti inflammatory drugs (NSAIDs), conventional disease modifying anti-rheumatic drugs (DMARDs) and, rarely, biologics in severe cases. We report the successful use of tofacitinib in four cases of reactive arthritis who failed to respond to conventional therapies.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Artrite Reativa
/
Antirreumáticos
Tipo de estudo:
Diagnostic_studies
/
Etiology_studies
Limite:
Humans
Idioma:
En
Revista:
Mod Rheumatol Case Rep
Ano de publicação:
2022
Tipo de documento:
Article
País de afiliação:
Índia
País de publicação:
Reino Unido